Navigation Links
ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease
Date:2/26/2009

will be evaluated in comparison to placebo. Ambulatory patients suffering from mild to moderate Alzheimer's disease are randomized and receive oral treatment, twice a day, of either 40 or 80 mg of EHT 0202, or placebo over a three-month period. The study design will also allow for the collection of preliminary data related to many clinical efficacy parameters of EHT 0202, notably including a battery of cognitive assessments (ADAS-Cog, NTB, MMSE) but also assessment of patients' daily living activities, global assessment and behaviour.

Study results will be available in Q4 2009.

About EHT 0202

EHT 0202 has a novel mechanism of action when compared to existing Alzheimer's disease therapeutics: it stimulates the alpha-secretase pathway, thus enhancing the production of the procognitive and neuroprotective sAPPalpha fragment of APP (Amyloid Precursor Protein). The stimulation of the alpha-secretase pathway being to the detriment of Abeta amyloid peptide production, EHT 0202 potentially reduces toxic Abeta plaque formation [1].

Phase I studies demonstrated good tolerability of EHT 0202 in both young and aged healthy volunteers; importantly, no sedation or emesis were observed clinically.

Preclinical studies have shown that EHT 0202 protects cortical neurons against Abeta42-induced stress and that this neuroprotection is associated with sAPPalpha induction. EHT 0202 has also demonstrated pro-cognitive properties in several animal models: age-related memory impairment and scopolamine-induced amnesia [2].

About Alzheimer's disease

Alzheimer's disease is the most frequent cause of dementia in the aging population. The World Health Organization estimated in 2001 that 18 million people around the world were suffering from Alzheimer's disease and that this figure could nearly double by 2025 to 34 million [3].

About ExonHit Therapeutics


'/>"/>

SOURCE ExonHit Therapeutics SA
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ExonHit Therapeutics Expands Strategic Collaboration With Allergan
2. ExonHits EHT 0202 Counters Scopolamines Detrimental Effects on Cognition in Humans
3. BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine
4. Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone
5. Cerenis Therapeutics In-Licenses Intellectual Property for New Treatment of Aortic Valve Stenosis
6. PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy
7. DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round
8. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
9. Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
10. Phico Therapeutics Receives GBP1 Million Award From the Wellcome Trust to Take Anti-MRSA Nasal Product Through Early Clinical Trials
11. Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... N.C. , July 31, 2015  In today,s ... customers who are increasingly mobile, increasingly connected, and increasingly ... growing variety of customer interaction channels and tools is ... including social media. According to research ... over the counter (OTC) segment in a call center ...
(Date:7/31/2015)... , July 31, 2015 Today, ... (NABP ® ) issued a report urging ... that action is taken against websites illegally selling ... Internet Drug Outlet Identification Program Progress Report for ... , thousands of websites illegally distribute medications ...
(Date:7/31/2015)... , July 31, 2015  Boston Children,s ... benefiting from 3D printing of their anatomy before ... life-threatening cerebrovascular malformations (abnormalities in the brain,s blood ... Reporting online today in the Journal of ... of 3D printing and synthetic resins to create ...
Breaking Medicine Technology:Best Practices in Building World-Class Consumer & Over-the-Counter Call Centers 2NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 2NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 33D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4
... Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: ... study examining the immunogenicity and safety profiles of Fluzone High-Dose ... adults to a standard dose of Fluzone vaccine. The data ... Diseases Society of America on October 21, 2011. ...
... 21, 2011 Approximately 100 cherry tree saplings were ... newest park in the Morris County Park System, located ... Lane and celebrate the 100th anniversary of the ... to Washington D.C. in 1912.  More than 75 Daiichi ...
Cached Medicine Technology:Sanofi Pasteur Presents New Data Confirming Fluzone® High-Dose (Influenza Virus Vaccine) Produces Higher Antibody Response in the Age 65+ Population 2Sanofi Pasteur Presents New Data Confirming Fluzone® High-Dose (Influenza Virus Vaccine) Produces Higher Antibody Response in the Age 65+ Population 3Sanofi Pasteur Presents New Data Confirming Fluzone® High-Dose (Influenza Virus Vaccine) Produces Higher Antibody Response in the Age 65+ Population 4Sanofi Pasteur Presents New Data Confirming Fluzone® High-Dose (Influenza Virus Vaccine) Produces Higher Antibody Response in the Age 65+ Population 5Sanofi Pasteur Presents New Data Confirming Fluzone® High-Dose (Influenza Virus Vaccine) Produces Higher Antibody Response in the Age 65+ Population 6Daiichi Sankyo, Inc. Brings the Legacy of Washington, DC Cherry Trees to New Jersey 2Daiichi Sankyo, Inc. Brings the Legacy of Washington, DC Cherry Trees to New Jersey 3Daiichi Sankyo, Inc. Brings the Legacy of Washington, DC Cherry Trees to New Jersey 4
(Date:8/3/2015)... ... August 03, 2015 , ... A July 13 article ... Stem Cells Found to Release Natural Painkiller That Can Last 'For Five Weeks'" ... to the report, the new study showed that harvesting stem cell-rich bone marrow from ...
(Date:8/3/2015)... ... ... Illinois Health & Science (IHS) has completed the purchase of IBA Molecular North ... NA’s cyclotron sites and research and development facilities. , “We are excited ... a large manufacturing hub in Noblesville, Indiana,” said Ken Smithmier, President and CEO of ...
(Date:8/3/2015)... ... August 03, 2015 , ... Hub International Insurance ... Williams has joined its growing California employee benefits division. Mr. Williams will ... his clients. Mr. Williams will be joining the newly integrated Northern California employee ...
(Date:8/3/2015)... ... August 03, 2015 , ... Cambia ... for overall performance of the company’s Medicare and Federal Employee Programs (FEP) lines ... to deliver better health for members. In this role, Scott is responsible for ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... risk management and investigative services, has introduced a new logo and comprehensive ... solutions that improve business outcomes for its customers. EMSI’s new tagline, “Powerful ...
Breaking Medicine News(10 mins):Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2Health News:Cambia Health Solutions Names Scott Powers President of Government Programs 2Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2
... ROCHESTER, Minn. -- Suicide is the 11th leading cause of ... think about taking their own lives. Sadly, each year tens ... shock to family and friends, some warning signs exist. Often ... to start a person toward help and treatment. ...
... August 1, 2011The dangers of cell phones have led to ... are simple ways to minimize the health risks associated with ... Lee Davis, PhD, MPH, President of the Environmental Health Trust, ... and Complementary Therapies , published by Mary Ann Liebert, Inc. ...
... Despite the popularity of colon cleansing, there,s no evidence ... or in day spas -- offers any health benefits, a ... side effects ranging from vomiting to kidney failure and death, ... also called colonic irrigation or colonic hydrotherapy -- often involves ...
... 2010 in Duisburg required medical care. The mass panic in ... more than 400 injured, some seriously. The emergency physician Ole ... an assessment of the medical care provided. Rather than focusing ... authors give an overview of the number, severity and urgency ...
... Attending a non-denominational spiritual retreat can help patients ... more hopeful about the future, a University of ... patients who participated in a four-day retreat that ... journal writing and outdoor activities saw immediate improvement ...
... The 2011 Annual Meeting & OTO EXPO of the ... Foundation (AAO-HNSF), the largest meeting of ear, nose, and ... 2011 in San Francisco, CA. Featuring more than ... instruction course hours for attendees, the annual meeting is ...
Cached Medicine News:Health News:Mayo Clinic: Primary physicians may hold key to suicide prevention 2Health News:Colon Cleansing Has No Health Benefit, May Harm: Report 2Health News:Love Parade 2010: Patient care during a tragedy 2Health News:Spiritual retreat can lower depression, raise hope in heart patients 2Health News:World's largest meeting of ear, nose and throat doctors 2
... The Maxi-Flo® suction catheter included with each ... trauma., ,All Portex® No Pour Pak® ... ,No Pour Pak® II suction ... nosocomial infections, protecting the patient and clinician ...
... Components packaged in order of ... Choice of multi-compartment trays allows ... Economical.Prevents waste by providing exact ... sterile or non-sterile. Stackable container ...
... Minimize Patient Trauma and Increase Staff ... Kits (10 Fr, 12 Fr, 14 Fr, ... Depth-Marked Suction Catheters with Contro-Vac Valves and ... the potential for inflammation,during suctioning. Each catheter ...
Touch-Trol Suction Catheter Mini-Tray...
Medicine Products: